Latest news

Thumbnail image for Takeda licenses Crescendo’s Humabodies

Takeda licenses Crescendo’s Humabodies

Japanese drug giant Takeda has taken an exclusive license to Cambridge, UK-based Crescendo Biologics’ Humabodies directed to one of its oncology targets.

5th November 2018

Thumbnail image for The PharmaTimes International Clinical Researcher of the Year – The Americas competition is now open for entry!

The PharmaTimes International Clinical Researcher of the Year – The Americas competition is now open for entry!

Designed to recognise and reward the talent and passion of industry and academic researchers, The PharmaTimes Clinical Researcher of the Year - The Americas is open to give contestants the ultimate challenge. A valuable learning and development opportunity for clinical researchers in pharma, clinical research organisations (CROs) and investigator sites who currently work in North, South and Central America.

5th November 2018

Thumbnail image for US expands reach of Keytruda in NSCLC

US expands reach of Keytruda in NSCLC

US regulators have approved MSD’s Keytruda, in combination with carboplatin and either paclitaxel or nab-paclitaxel, for the first-line treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC).

2nd November 2018

Thumbnail image for FDA advisors turn down Alkermes’ ALKS 5461

FDA advisors turn down Alkermes’ ALKS 5461

Alkermes’ ALKS 5461 has been hit with a potential setback in the US after regulatory advisors failed to back its approval for major depressive disorder (MDD).

2nd November 2018

Previous  --   13 14 15 16 17 18 19 20 21 22   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download